Develops vaccine for the treatment of cancer
Company profile
Ticker
VGEN
Exchange
CEO
Andrew L. Tussing
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Latest filings (excl ownership)
REVOKED
Registration or securities revoked
26 Apr 19
8-K
Entry into a Material Definitive Agreement
1 Jul 16
8-K
Regulation FD Disclosure
10 Jun 16
8-K
Entry into a Material Definitive Agreement
13 May 16
8-K
Entry into a Material Definitive Agreement
8 Apr 16
NT 10-K
Notice of late annual filing
31 Mar 16
8-K
Entry into a Material Definitive Agreement
1 Mar 16
8-K
Entry into a Material Definitive Agreement
1 Dec 15
8-K
Entry into a Material Definitive Agreement
18 Nov 15
10-Q
2015 Q3
Quarterly report
16 Nov 15
Latest ownership filings
SC 13G
Vaccinogen Inc
13 Feb 17
4
MICHAEL G HANNA JR
7 Jul 15
SC 13G/A
Vaccinogen Inc
7 Jul 15
4
MICHAEL G HANNA JR
7 Jul 15
4
ANDREW TUSSING
7 Jul 15
3/A
MICHAEL G HANNA JR
7 Jul 15
SC 13G/A
Vaccinogen Inc
1 May 15
SC 13D
Vaccinogen Inc
1 May 15
4
RONALD W KAISER
22 Apr 15
4
ANDREW TUSSING
22 Apr 15
Institutional ownership, Q4 2023
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 1 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|